Advancing Therapies for Rare Liver Diseases and Alagille Syndrome with FDA Approved LIVMARLI with Chris Peetz - CEO of Mirum Pharmaceuticals
ONCE UPON A GENE - EPISODE 137
Advancing Therapies for Rare Liver Diseases and Alagille Syndrome with FDA Approved LIVMARLI with Chris Peetz - CEO of Mirum Pharmaceuticals
Chris Peetz is the CEO of Mirum Pharmaceuticals, a pharmaceutical company focused on rare liver diseases. They work closely with patients and advocacy groups and have genuine connections which reinforces their sense of urgency to create treatments for liver-related diseases and help to make lives better.
EPISODE HIGHLIGHTS
How was Mirum founded?
Our current programs include two different medicines. LIVMARLI (maralixibat) is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.